195 related articles for article (PubMed ID: 8039991)
1. Implantable cardioverter defibrillators: a guide for clinicians.
Davidson T; VanRiper S; Harper P; Wenk A
Heart Lung; 1994; 23(3):205-15; quiz 216-7. PubMed ID: 8039991
[TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
Groh WJ; Foreman LD; Zipes DP
Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
[TBL] [Abstract][Full Text] [Related]
3. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
4. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
5. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
[TBL] [Abstract][Full Text] [Related]
6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
7. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
[TBL] [Abstract][Full Text] [Related]
8. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
Siebels J; Schneider MA; Kuck KH
Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
[TBL] [Abstract][Full Text] [Related]
9. Update on implantable cardioverter defibrillators: knowing the differences in devices and their impact on patient care.
Nichols K; Collins J
AACN Clin Issues; 1995 Feb; 6(1):31-43. PubMed ID: 7736302
[TBL] [Abstract][Full Text] [Related]
10. Development of device therapy for ventricular arrhythmias.
Holley LK
Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
[TBL] [Abstract][Full Text] [Related]
11. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
Mitchell AR
Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
[TBL] [Abstract][Full Text] [Related]
12. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
[TBL] [Abstract][Full Text] [Related]
13. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
14. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
Ganjehei L; Nazeri A; Massumi A; Razavi M
Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
[TBL] [Abstract][Full Text] [Related]
15. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
16. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
Maagh P; Trappe HJ; Meissner A
Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
[TBL] [Abstract][Full Text] [Related]
17. Delayed termination of ventricular tachycardia after cardioversion.
Stiles MK; Lau DH; Young GD; Sanders P
Europace; 2007 Sep; 9(9):730-1. PubMed ID: 17639067
[TBL] [Abstract][Full Text] [Related]
18. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation in patients with implantable defibrillators.
Sakhuja R; Shah AJ; Keebler M; Thakur RK
Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
